The Cures Act amended the Public Health Service Act to require, with limited exceptions, a single IRB of record for federally funded cooperative research, harmonizing with the 2018 Common Rule revisions. It also accelerated FDA's adoption of real-world evidence and patient-experience data in regulatory decisions.